Related Experiment Video
Updated: Jun 22, 2025
07:18
Author Spotlight: A Unique Mouse Model of Asphyxia-Induced Cardiac Arrest
Published on: April 14, 2023
1.7K
Can Artificial Intelligence Enhance Syncope Management?: A JACC: Advances Multidisciplinary Collaborative Statement
Giselle M Statz1, Aron Z Evans2, Samuel L Johnston1
1Division of Cardiovascular Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
JACC. Advances
|June 28, 2024
Summary
Artificial intelligence (AI) may improve syncope management by aiding diagnosis and risk assessment. This can lead to better patient outcomes and reduced healthcare costs, though challenges remain.
Area of Science:
- Cardiology
- Medical Informatics
Background:
- Syncope (transient loss of consciousness) presents diagnostic and risk stratification challenges.
- Current algorithms often lead to unnecessary hospitalizations and high costs.
- Adverse cardiovascular outcomes, though concerning, are rare in syncope patients.
Purpose of the Study:
- To explore the potential of Artificial Intelligence (AI) in syncope management.
- To highlight AI's role in improving diagnosis, risk assessment, and treatment decisions.
- To encourage the development of AI-driven clinical decision support tools for syncope.
Main Methods:
- This is a collaborative statement from a multidisciplinary group.
- Focuses on the potential applications and challenges of AI in syncope.
- Reviews current limitations in syncope risk stratification and management.
Main Results:
- AI may enhance the definition and diagnosis of transient loss of consciousness events.
- AI tools could predict syncope recurrence and guide hospitalization decisions.
- Potential exists for AI to streamline diagnostics and reduce healthcare expenses.
Conclusions:
- AI offers significant promise for optimizing syncope patient care.
- Development of AI-derived tools can improve outcomes and efficiency.
- Addressing medicolegal and ethical concerns is crucial for AI implementation in syncope.
Related Concept Videos
01:17Ischemic Heart Disease: Overview
1.3K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
01:22Alzheimer's Disease: Treatment
178
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
178
01:20Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
01:19Management of Insomnia
243
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
243
01:13Seizures: Classification
331
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
331
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
2.2K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.2K